Mometasone Furoate Generic Name & Formulations
Mometasone furoate 0.1%; crm; oint.
Crm, oint—contact supplier; Lotion—30mL, 60mL
Mometasone Furoate Indications
Mometasone Furoate Dosage and Administration
Adults and Children
<2yrs: not recommended. ≥2yrs: apply thin film once daily; max 3 weeks' therapy for children. Discontinue when control is achieved. Do not occlude.
Mometasone Furoate Contraindications
Mometasone Furoate Boxed Warnings
Mometasone Furoate Warnings/Precautions
Avoid use near eyes, on face, groin, or axillae. Do not use for diaper dermatitis. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, or reduce dose or potency if occurs. Increased risk of posterior subcapsular cataracts and glaucoma; monitor for visual symptoms. Treat infection if present; discontinue if infection persists or worsens. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
Mometasone Furoate Pharmacokinetics
Mometasone Furoate Interactions
Mometasone Furoate Adverse Reactions
Burning, pruritus, skin atrophy, tingling/stinging, furunculosis, acneiform reaction, folliculitis; allergic contact dermatitis (discontinue if irritation occurs), HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia.
Mometasone Furoate Clinical Trials
Mometasone Furoate Note
Formerly known under the brand name Elocon.
Mometasone Furoate Patient Counseling